TRAW Stock Analysis: Buy, Sell, or Hold?
TRAW - Traws Pharma, Inc. Common Stock
$2.04
0.00 (0.00%)
▲
5d:
-27.66%
30d:
+53.38%
90d:
-20.62%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Get Alerted When TRAW Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called TRAW this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TRAW is down 27.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TRAW is down 27.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TRAW is currently trading at $2.04, which is considered fair relative to its 30-day fair value range of $1.29 to $2.39.
Technical Outlook: Technically, TRAW is in a downtrend. Immediate support is located at $1.91, while resistance sits at $2.98.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+292.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TRAW is in a downtrend. Immediate support is located at $1.91, while resistance sits at $2.98.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+292.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.29 -
$2.39
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 292.2% below Wall St target ($8.00)
- WARNING: Recommendation downgraded due to -27.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.29 -
$2.39
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.91
Resistance Level
$2.98
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.89
Wall Street Target
$8.00
(+292.2%)
Revenue Growth (YoY)
4694.7%
Last updated: February 04, 2026 1:36 AM ET
Data refreshes hourly during market hours. Next update: 2:36 AM
Data refreshes hourly during market hours. Next update: 2:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRAW showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 61 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 63 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 59 HOLD |